Watch the full live broadcast with Diamyd Medicals vd Ulf Hannelius below.
Watch Diamyd Medical's live broadcast at BioStock
Text:
Hanna Norrlid | [email protected]
Today, Wednesday, October 8, BioStock broadcast a live interview with Diamyd Medical's CEO Ulf Hannelius. The broadcast began with a presentation of the company's GAD technology, how far the phase III study has come and the path to market. He then answered shareholders' questions regarding the study design, timelines and commercialization strategy as well as the company's market analysis and possible future pricing. You can now watch the broadcast afterwards.